Koers CELK AB Nasdaq Stockholm
Aandelen
SE0009189657
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 2,49 mld. 230 mln. 0 214 mln. | Omzet 2025 * | 2,89 mld. 267 mln. 0 248 mln. | Marktkapitalisatie | 3,27 mld. 303 mln. 0 281 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 14 mln. 1,29 mln. - 1,2 mln. | Nettowinst (verlies) 2025 * | 131 mln. 12,11 mln. - 11,25 mln. | EV/omzet 2024 * | 1,86 x |
Nettoschuld 2024 * | 1,36 mld. 126 mln. 0 117 mln. | Nettoschuld 2025 * | 1,67 mld. 154 mln. 0 143 mln. | EV/omzet 2025 * | 1,71 x |
K/w-verhouding 2024 * |
232
x | K/w-verhouding 2025 * |
24,9
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 60,54% |
Recentste transcriptie over CELK AB
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 52 | 20/11 | |
Erik Gatenholm
FOU | Founder | 35 | 01-03-15 |
Director of Finance/CFO | 39 | 01-12-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rolf Classon
CHM | Chairman | 79 | 26-04-22 |
John Mackay
BRD | Director/Board Member | 62 | 01-01-23 |
Director/Board Member | 68 | 18-12-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,84% | 218 mld. | |
+7,35% | 184 mld. | |
+13,04% | 135 mld. | |
+26,03% | 107 mld. | |
-1,33% | 62,38 mld. | |
+4,81% | 50,9 mld. | |
+0,30% | 40,87 mld. | |
+2,78% | 36,28 mld. | |
+26,14% | 31,88 mld. |